A number of research firms have changed their ratings and price targets for Shire PLC (LON: SHP):

  • 6/9/2017 – Shire PLC had its price target lowered by analysts at Jefferies Group LLC from GBX 6,400 ($80.96) to GBX 5,600 ($70.84). They now have a “buy” rating on the stock.
  • 6/9/2017 – Shire PLC had its “overweight” rating reaffirmed by analysts at Barclays PLC. They now have a GBX 6,300 ($79.70) price target on the stock, down previously from GBX 6,500 ($82.23).
  • 6/8/2017 – Shire PLC had its price target lowered by analysts at Berenberg Bank from GBX 6,100 ($77.17) to GBX 6,000 ($75.90). They now have a “buy” rating on the stock.
  • 6/1/2017 – Shire PLC was downgraded by analysts at Liberum Capital to a “hold” rating. They now have a GBX 4,900 ($61.99) price target on the stock, down previously from GBX 5,500 ($69.58).
  • 5/26/2017 – Shire PLC had its “buy” rating reaffirmed by analysts at Liberum Capital. They now have a GBX 5,500 ($69.58) price target on the stock.
  • 5/19/2017 – Shire PLC had its “buy” rating reaffirmed by analysts at Deutsche Bank AG. They now have a GBX 6,100 ($77.17) price target on the stock.
  • 5/19/2017 – Shire PLC had its “overweight” rating reaffirmed by analysts at J P Morgan Chase & Co. They now have a GBX 6,000 ($75.90) price target on the stock.
  • 5/19/2017 – Shire PLC was downgraded by analysts at HSBC Holdings plc to a “reduce” rating. They now have a GBX 4,450 ($56.29) price target on the stock, down previously from GBX 4,550 ($57.56).
  • 5/19/2017 – Shire PLC had its “overweight” rating reaffirmed by analysts at Barclays PLC. They now have a GBX 6,500 ($82.23) price target on the stock.
  • 5/17/2017 – Shire PLC had its “buy” rating reaffirmed by analysts at Citigroup Inc.. They now have a GBX 6,500 ($82.23) price target on the stock.
  • 5/11/2017 – Shire PLC had its “buy” rating reaffirmed by analysts at Berenberg Bank. They now have a GBX 5,900 ($74.64) price target on the stock.
  • 5/10/2017 – Shire PLC had its price target lowered by analysts at Deutsche Bank AG from GBX 6,300 ($79.70) to GBX 6,100 ($77.17). They now have a “buy” rating on the stock.
  • 5/4/2017 – Shire PLC had its “buy” rating reaffirmed by analysts at Citigroup Inc.. They now have a GBX 6,500 ($82.23) price target on the stock.
  • 5/3/2017 – Shire PLC had its “outperform” rating reaffirmed by analysts at Credit Suisse Group. They now have a GBX 5,400 ($68.31) price target on the stock.
  • 5/3/2017 – Shire PLC had its “buy” rating reaffirmed by analysts at Liberum Capital. They now have a GBX 5,500 ($69.58) price target on the stock.
  • 5/3/2017 – Shire PLC had its “buy” rating reaffirmed by analysts at Jefferies Group LLC. They now have a GBX 6,400 ($80.96) price target on the stock.
  • 5/3/2017 – Shire PLC had its “buy” rating reaffirmed by analysts at Deutsche Bank AG. They now have a GBX 6,300 ($79.70) price target on the stock.
  • 5/3/2017 – Shire PLC had its “overweight” rating reaffirmed by analysts at J P Morgan Chase & Co. They now have a GBX 6,000 ($75.90) price target on the stock.
  • 5/3/2017 – Shire PLC had its “hold” rating reaffirmed by analysts at HSBC Holdings plc. They now have a GBX 4,550 ($57.56) price target on the stock.
  • 5/3/2017 – Shire PLC had its “buy” rating reaffirmed by analysts at Goldman Sachs Group, Inc. (The). They now have a GBX 6,800 ($86.02) price target on the stock.
  • 5/3/2017 – Shire PLC had its “overweight” rating reaffirmed by analysts at Barclays PLC. They now have a GBX 6,500 ($82.23) price target on the stock.
  • 5/2/2017 – Shire PLC had its “buy” rating reaffirmed by analysts at Shore Capital.
  • 4/27/2017 – Shire PLC had its “outperform” rating reaffirmed by analysts at Royal Bank Of Canada.
  • 4/27/2017 – Shire PLC had its “conviction-buy” rating reaffirmed by analysts at Goldman Sachs Group, Inc. (The). They now have a GBX 6,800 ($86.02) price target on the stock.
  • 4/24/2017 – Shire PLC had its “buy” rating reaffirmed by analysts at Shore Capital.
  • 4/21/2017 – Shire PLC had its “overweight” rating reaffirmed by analysts at J P Morgan Chase & Co.
  • 4/19/2017 – Shire PLC had its “outperform” rating reaffirmed by analysts at Credit Suisse Group. They now have a GBX 5,400 ($68.31) price target on the stock.

Shire PLC (LON:SHP) traded down 0.35% during midday trading on Monday, reaching GBX 4330.50. 2,242,160 shares of the company’s stock traded hands. Shire PLC has a 52-week low of GBX 2,707.19 and a 52-week high of GBX 5,377.00. The firm’s market cap is GBX 39.15 billion. The firm’s 50-day moving average is GBX 4,618.26 and its 200 day moving average is GBX 4,637.65.

In other news, insider William Burns bought 136 shares of the company’s stock in a transaction dated Friday, March 31st. The shares were purchased at an average price of GBX 4,742 ($59.99) per share, for a total transaction of £6,449.12 ($8,158.28).

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.